Small Caps has reported on the follow-up results from our CelGro™ tendon regeneration clinical trial, confirming all patients with rotator cuff injuries achieved a successful tendon repair with no need for revision surgeries.
Orthocell’s pre-clinical results for the use of CelGro™ in enhancing the repair of severed peripheral nerves have been featured in Small Caps.
Small Caps has featured the outcomes of Orthocell’s single-stage dental implant study, evaluating treatment with our CelGro™ collagen membrane.
Orthcell’s planned equity raise has been featured in AFR’s Street Talk.
Orthocell CEO Paul Anderson spoke to BioWorld Asia about the interim results of our nerve regeneration trial, that saw patients regain sensation and muscle function following Celgro™ nerve regeneration treatment.
Early results from Orthocell’s nerve regeneration study have been featured in Small Caps. Read the article HERE.
Small Caps has featured the results from Orthocell’s recent study that shows an 82% success rate using its novel stem cell therapy treatment for chronic tendon injuries.
For 34-year-old Daniel Kerr, sport is life. The talented Perth-born Australian rules footballer, best known for playing 220 games for the West Coast Eagles between 2001 and 2013, is no stranger to pain for gain.
Channel 7 News Perth has showcased Orthocell’s successful tendon treatment therapy for AFL star Daniel Kerr.
What happens when you bring 90+ expert dentistry and maxillofacial surgeon’s together in a room to unpack the burgeoning world of collagen membrane technology and digital dentistry?